Schedule 13G ownership disclosure
ZIOPHARM ONCOLOGY INC
Security class unavailable · CUSIP: 98973P101
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 11,633,700
- Percent of class
- 5.3800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-018959
- Form type
- SC 13G
- Filer
- Alaunos Therapeutics, Inc.
- CIK
- CIK 1107421
- Filed
- Feb 10, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership